TB drug resistance research targets a new pathway for treatment

Weill Cornell Medicine's work on tuberculosis drug resistance could eventually reduce deaths from a disease killing millions annually

Weill Cornell Medicine's research identifies a potential target for curbing tuberculosis drug resistance. This work could eventually enable treatments for a disease killing millions annually. However, the source reporting this research is currently unreachable, so no verification exists. If validated, such treatments might reduce TB-related healthcare costs and deaths — but this remains theoretical at present.

The source is unreachable and provides no specific claims. This brief reflects only the metadata's description of the research direction.

Source: Phys.org